
    
      Prospective, single arm, short term study with correlative biomarker endpoints. Two hundred
      (200) newly diagnosed breast cancer patients will be recruited to participate in a short term
      (30 day) Phase 0 biomarker evaluation study prior to surgical resection. Patients will be
      receive fish Oil (Omega-3 FFAs, 2700 mg by mouth twice daily).
    
  